Stocks Health care LFST
NASDAQ · Health careLifeStance Health Group, Inc. (LFST)
LifeStance Health Group, Inc. brought in $1.7B of revenue over the twelve months to September 30, 2026, up 22.6% from a year earlier. Net income was $71.9M, a net margin of 4.3%. Operating cash flow minus capital spending left $110M of free cash flow in fiscal 2025. At September 30, 2026 it held $218.8M in cash against $271.9M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about LifeStance Health Group, Inc.
- Net worth
- LifeStance Health Group, Inc. has a market value (market cap) of $5.6B at the latest share price, and shareholders' equity of $1.5B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.4B (+13.9% year on year), with net income of $9.7M. Over the 12 months to September 30, 2026: revenue $1.7B, net income $71.9M.
- Cash flow
- In fiscal 2025 operations brought in $146.2M of cash; after $36.1M of capital spending, free cash flow was $110M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- LifeStance Health Group, Inc.'s next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What LifeStance Health Group, Inc. does
LifeStance Health Group, Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker LFST.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.4B | $9.7M | n/a | $110M |
| 2024 | $1.3B | -$57.4M | n/a | $85.7M |
| 2023 | $1.1B | -$186.3M | n/a | -$57.4M |
| 2022 | $859.5M | -$215.6M | n/a | -$26.5M |
| 2021 | $667.5M | -$307.2M | n/a | -$85.1M |
| 2019 | $212.5M | $5.7M | n/a | $2.7M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where LFST ranks in Health care
Latest SEC filings
What LifeStance Health Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 25% to $455.9M versus the same quarter last year; net income rose 1,978% to $22.4M.
- November 5, 2026
- October 16, 2026
- October 5, 2026Passive stake changed SCHEDULE 13G/A
- September 11, 2026Other event 8-K
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 11, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 26% to $435.4M versus the same quarter last year; net income of $23.6M versus a net loss of $3.8M.
- August 6, 2026
- July 29, 2026Passive stake (5% or more) SCHEDULE 13G
What is LFST worth? A DCF from its reported cash flow
Insider trades
What the people running LifeStance Health Group, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $227.1M worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 22, 2026 | Bourdon DavidChief Executive Officer, Director | Gave as a gift | 150,000 | - |
| September 22, 2026 | Bourdon DavidChief Executive Officer, Director | Gave as a giftindirect | 150,000 | - |
| September 22, 2026 | Bourdon DavidChief Executive Officer, Director | Gave as a gift | 150,000 | - |
| September 22, 2026 | Bourdon DavidChief Executive Officer, Director | Gave as a giftindirect | 150,000 | - |
| September 11, 2026 | Tpg Gp A, LLC10% owner | Soldindirect | 18,409,705 | $226.3M |
| September 2, 2026 | Paunovich VukasinChief Technology Officer | Sold | 42,067 | $541.4K |
| September 2, 2026 | Bourdon DavidChief Executive Officer, Director | Other change | 150,000 | - |
| August 24, 2026 | Varanakis AnnChief People Officer | Shares withheld for tax | 8,156 | $99.2K |
Who owns LFST
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Tpg GP A, LLC13G, passive with 2 related filers | 25.7% | August 14, 2026 |
| Fmr LLC13G, passive with 1 related filers | 15% | May 6, 2026 |
| Summit Partners, L.P.13G, passive with 5 related filers | 6.1% | August 11, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 287 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Tpg GP A, LLC | 111,744,614 | -28,281,943 |
| Fmr LLC | 58,252,466 | -433,014 |
| BlackRock, Inc. | 36,348,507 | +18,213,556 |
| Summit Partners L P | 23,310,115 | -5,899,661 |
| Vanguard Portfolio Management LLC | 13,960,892 | +4,278,587 |
| Jennison Associates LLC | 12,077,557 | +1,848,756 |
| Dimensional Fund Advisors LP | 11,427,602 | +1,059,922 |
| Vanguard Capital Management LLC | 9,735,076 | +1,826,917 |
| State Street Corp | 8,228,351 | +4,134,857 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5,947,600 | -144,623 |
| Geode Capital Management, LLC | 5,592,598 | +867,444 |
| Morgan Stanley | 5,021,527 | +1,580,301 |
| Principal Financial Group Inc | 3,996,866 | +919,211 |
| Millennium Management LLC | 3,606,755 | +1,707,706 |
| First Eagle Investment Management, LLC | 3,125,932 | +1,515,466 |
| Nuveen, LLC | 3,061,724 | +850,792 |
| Integral Health Asset Management, LLC | 3,000,000 | -1,300,000 |
| Wellington Management Group Llp | 2,883,371 | new |
| Northern Trust Corp | 2,137,906 | +603,053 |
| Woodline Partners LP | 2,068,445 | +253,224 |
Insiders
17 insiders reported holding 111,901,381 shares in total, about $1.63B at the last price.
| Holder | Shares |
|---|---|
| Tpg Gp A, LLC10% owner | 79,691,70279,691,702 held indirectly |
| Black Darren M.Director | 23,310,11523,310,115 held indirectly |
| Burdick Kenneth ADirector | 2,970,810 |
| Bourdon DavidChief Executive Officer, Director | 1,098,247150,000 held indirectly |
| Pardo RyanSee Remarks, Director | 1,093,366 |
| Shuey EricDirector | 867,562867,562 held indirectly |
| McGroarty RyanSee Remarks | 772,235 |
| Bessler RobertDirector | 731,925656,560 held indirectly |
| Varanakis AnnChief People Officer | 413,881 |
| Miller Lisa KChief Operating Officer | 281,289 |
Questions about LFST
What does LifeStance Health Group, Inc. do?
LifeStance Health Group, Inc. is a company in the Health care sector, listed on NASDAQ as LFST. Its shares trade on NASDAQ under the ticker LFST.
What is LifeStance Health Group, Inc.'s net worth?
LifeStance Health Group, Inc. has a market value (market cap) of $5.6B at the latest share price, and shareholders' equity of $1.5B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is LifeStance Health Group, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $71.9M on revenue of $1.7B, a net margin of 4.3%.
How much revenue does LifeStance Health Group, Inc. make?
Over the twelve months to September 30, 2026 LifeStance Health Group, Inc. reported revenue of $1.7B. That is 22.6% more than a year earlier.
When did LifeStance Health Group, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the planned insider sale from November 9, 2026.
When is LifeStance Health Group, Inc.'s next earnings report?
LifeStance Health Group, Inc.'s next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare LFST with
Follow LFST
Get an email when LifeStance Health Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values LifeStance Health Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.